Nuvation Bio Gains FDA Fast Track for Safusidenib
New York, New York, August 20, 2026 Nuvation Bio Inc. has announced that the U.S. Food and Drug Administration...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
New York, New York, August 20, 2026 Nuvation Bio Inc. has announced that the U.S. Food and Drug Administration...
Silver Spring, Maryland, August 19, 2026 The U.S. Food and Drug Administration (FDA) has authorized Aletta, a first-of-its-kind standalone...
Jena, Germany, August 19, 2026 ZEISS Medical Technology, part of Carl Zeiss Meditec AG, has announced that the U.S....
Coral Gables, Florida, August 18, 2026 Sitero, a global clinical research organization (CRO) and clinical technology company, has announced...
Irvine, Calif., July 27, 2026 Masimo, a Danaher company and global leader in patient monitoring technologies, has received U.S....
